Future studies revealed that TLBZT induces cell senescence in cancer cells by regulating the levels of p21 and p16, and inhibiting the phosphorylation of Rb, ultimately leading to cell cycle arrest and potential anticancer effects [659,660]. Here, CDKN2A is linked to cancer.